Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Verrica Pharmaceuticals

Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), headquartered in West Chester, PA, is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. For more information, visit www.verrica.com.

Verrica Pharmaceuticals Inc
Business

Verrica Pharmaceuticals Advances Global Phase 3 Trial for YCANTH with Amended Torii Agreement

July 2, 2025July 1, 2025 - by Timothy Alexander

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced an amended collaboration and licensing agreement with Torii Pharmaceutical Co. Ltd. to initiate a global Phase 3 clinical trial …

Verrica Pharmaceuticals Advances Global Phase 3 Trial for YCANTH with Amended Torii Agreement Read More

Verrica Pharmaceuticals Inc
Public Companies

Verrica Pharmaceuticals to Present at Jefferies Global Healthcare Conference

May 29, 2025May 28, 2025 - by Timothy Alexander

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced that its President and Chief Executive Officer, Jayson Rieger, PhD, MBA, will speak at the prestigious Jefferies Global Healthcare …

Verrica Pharmaceuticals to Present at Jefferies Global Healthcare Conference Read More
Verrica Pharmaceuticals Inc
Finance

Verrica Pharmaceuticals Reports Record Q1 Revenue and Advancements in Pipeline

May 18, 2025May 17, 2025 - by Timothy Alexander

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced significant progress in the first quarter of 2025, reporting $3.4 million in revenue from YCANTH. This figure reflects a …

Verrica Pharmaceuticals Reports Record Q1 Revenue and Advancements in Pipeline Read More

Verrica Pharmaceuticals Inc
Public Companies

Verrica Pharmaceuticals CEO to Present at Citizens Life Sciences Conference

May 4, 2025May 3, 2025 - by Timothy Alexander

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer, will represent the company at the Citizens Life Sciences Conference …

Verrica Pharmaceuticals CEO to Present at Citizens Life Sciences Conference Read More
Verrica Pharmaceuticals Inc
Public Companies

Verrica Pharmaceuticals Reports Strong First-Quarter Growth for YCANTH

April 9, 2025April 8, 2025 - by Timothy Alexander

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced robust demand-led growth for its molluscum contagiosum treatment, YCANTH®, during the first quarter of 2025. The company reported a …

Verrica Pharmaceuticals Reports Strong First-Quarter Growth for YCANTH Read More

Verrica Pharmaceuticals Inc
Public Companies

Verrica Pharmaceuticals Adds Dr. Gavin Corcoran to Board of Directors

April 3, 2025April 3, 2025 - by Timothy Alexander

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced the appointment of Dr. Gavin Corcoran to its Board of Directors.

Verrica Pharmaceuticals Adds Dr. Gavin Corcoran to Board of Directors Read More
Verrica Pharmaceuticals Inc
Public Companies

Verrica Pharmaceuticals to Present at Needham Healthcare Conference

April 2, 2025April 1, 2025 - by Timothy Alexander

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology-focused therapeutics company, has announced its participation in the 24th Annual Needham Virtual Healthcare Conference. Jayson Rieger, PhD, MBA, President and …

Verrica Pharmaceuticals to Present at Needham Healthcare Conference Read More

Verrica Pharmaceuticals Inc
Executives

Verrica Pharmaceuticals Appoints Dr. Noah Rosenberg as Chief Medical Officer

March 28, 2025March 27, 2025 - by Timothy Alexander

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced the appointment of Dr. Noah L. Rosenberg as Chief Medical Officer, a strategic move aimed at strengthening the company’s efforts …

Verrica Pharmaceuticals Appoints Dr. Noah Rosenberg as Chief Medical Officer Read More
Verrica Pharmaceuticals Inc
Finance

Verrica Pharmaceuticals Reports Q4 2024 Growth and Pipeline Progress

March 13, 2025March 12, 2025 - by Timothy Alexander

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has reported its financial results for the fourth quarter and full year ending December 31, 2024, marking significant progress in its turnaround …

Verrica Pharmaceuticals Reports Q4 2024 Growth and Pipeline Progress Read More
Verrica Pharmaceuticals Inc
Public Companies

Verrica Pharmaceuticals CEO to Speak at TD Cowen 45th Annual Health Care Conference

February 26, 2025February 26, 2025 - by Timothy Alexander

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced that its President and CEO, Jayson Rieger, PhD, MBA, will participate in a fireside chat at the TD Cowen 45th …

Verrica Pharmaceuticals CEO to Speak at TD Cowen 45th Annual Health Care Conference Read More

Posts pagination

Previous 1 2 3 4 Next

Trending News

  • HUD Unleashes $4.4M Blitz to Wipe Out Lead Poisoning in U.S. Homes

  • New Task Forces Race to Protect Pennsylvania Seniors as Abuse Cases Surge

  • Vandal Strikes Main Street Business in Late-Night Rampage

  • Gun Pulled in South Street Jewelry Store Dispute, Suspect Still at Large

  • Loaded Gun and 200 Grams of Marijuana Seized in Wilmington Traffic Stop

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Secretary Scott Turner

HUD Unleashes $4.4M Blitz to Wipe Out Lead Poisoning in U.S. Homes

January 12, 2026January 11, 2026

Old woman sitting while talking

New Task Forces Race to Protect Pennsylvania Seniors as Abuse Cases Surge

January 12, 2026January 12, 2026

Vandalism, 4202 Main St

Vandal Strikes Main Street Business in Late-Night Rampage

January 12, 2026January 12, 2026

Copyright © 2026 MyChesCo.